rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Rein Therapeutics, Inc.

RNTX · Nasdaq

Health CareBiotechnologyNot moving yet

RNTX stood above a rising 150-day average in 4 of the last 52 weekly readings, and has been out of that trend for the last 25 weeks. It is 45.2% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 25
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$700K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
58 (+15)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$408KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months9
Sale orders, 12 months0
Buyers · sellers4 · 0
WhoDidSharesTraded
Rickenbach Josef H. VonDirectorbought4,500at $1.0727 May 2026filed 28 May 2026
Rickenbach Josef H. VonDirectorbought23,190at $1.0626 May 2026filed 28 May 2026
Rickenbach Josef H. VonDirectorbought15,950at $1.0522 May 2026filed 28 May 2026
Rickenbach Josef H. VonDirectorbought3,420at $1.0421 May 2026filed 28 May 2026
James Brian WindsorDirector, Officerbought25,000at $1.0030 Apr 2026filed 13 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders58+15 on the quarter
New · exited21 · 6
Reported value$42.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Voss Capital, LPadded · filed 14 Aug 20265,261,921$5.5M+873,559+19.9%
Cable Car Capital, LPadded · filed 14 Aug 20265,195,000$5.4M+4,775,000+1136.9%
ADAR1 Capital Management, LLCnew · filed 14 Aug 20264,500,000$4.7M+4,500,000
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20263,377,910$3.5M+2,379,389+238.3%
BIOS Capital Management, LPadded · filed 14 Aug 20262,982,375$3.1M+1,000,000+50.4%
Ikarian Capital, LLCnew · filed 14 Aug 20262,950,000$3.1M+2,950,000
GREAT POINT PARTNERS LLCnew · filed 14 Aug 20262,575,000$2.7M+2,575,000
CITADEL ADVISORS LLCnew · filed 14 Aug 20262,438,711$2.5M+2,438,711
Velan Capital Investment Management LPnew · filed 14 Aug 20261,700,000$1.8M+1,700,000
Senvest Management, LLCadded · filed 14 Aug 20261,230,895$1.3M+1,000,000+433.1%
31 Mar 2023 – 30 Jun 2026
163656Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Josef H. Von Rickenbach Company insiderDirector · last 27 May 202611 · 0
James Brian Windsor Company insiderDirector, Officer · last 8 May 20264 · 0
Voss Value Master Fund, Lp Company insider10% owner · last 14 Nov 20251 · 0
Voss Value-Oriented Special Situations Fund, Lp Company insider10% owner · last 28 Oct 20253 · 0
Alan A. Musso Company insiderDirector · last 23 Jul 20250 · 0
Manuel Aivado Company insiderDirector · last 23 Jul 20251 · 0
Reinhard J. Ambros Company insiderDirector · last 23 Jul 20252 · 0
William Fairey Company insiderDirector · last 23 Jul 20250 · 0
University Of Texas/texas Am Investment Management Co Company insider10% owner · last 17 Jun 20240 · 12
Jeffrey Allen Bailey Company insiderDirector · last 15 Jun 20223 · 0
Jodie Pope Morrison Company insiderDirector · last 15 Jun 20220 · 0
Nolan Howard Sigal Company insiderDirector · last 15 Jun 20220 · 0

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 24 Mar 20261.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$3.2M

Analyst forecasts

No analyst forecasts yet.